醫學工程學院

Medicine and Dentistry

1. Acute Kidney Injury 6%
2. Adverse Event 8%
3. Aminolevulinic Acid 6%
4. Analgesia 6%
5. Anterior Cruciate Ligament Reconstruction 7%
6. Apoplexy 24%
7. Biological Marker 12%
8. Bleeding 6%
9. Blood Transfusion 7%
10. Bone Defect 6%
11. Bone Graft 8%
12. Bone Regeneration 7%
13. Bone Substitutes 6%
14. Breast Cancer 18%
15. Cancer Cell 17%
16. Cell Proliferation 8%
17. Cell Therapy 12%
18. Cell Viability 6%
19. Chondrocyte 16%
20. Chronic Kidney Disease 22%
21. Clinical Trial 9%
22. Cohort Analysis 10%
23. Combination Therapy 10%
24. COVID-19 10%
25. Dental Implant 7%
26. Diabetes 8%
27. Diabetes Mellitus 11%
28. Diagnosis 6%
29. Disease 19%
30. Dry Eye 7%
31. Electrostimulation 7%
32. End Stage Renal Disease 7%
33. Endothelial Cell 8%
34. Epidermal Growth Factor Receptor 7%
35. Ex Vivo 6%
36. Fibroblast 10%
37. Functional Electrical Stimulation 8%
38. Gelatin 11%
39. Glioblastoma 6%
40. Growth Factor 12%
41. Hazard Ratio 6%
42. Health Care Cost 7%
43. Hemodialysis 13%
44. Hydroxylapatite 6%
45. Implant 19%
46. In Vitro 42%
47. Infection 10%
48. Injury 20%
49. Isotopes of Calcium 14%
50. Knee 14%
51. Knee Osteoarthritis 8%
52. Magnetic Resonance Imaging 16%
53. Malignant Neoplasm 28%
54. Medicine 16%
55. Mesenchymal Stem Cell 14%
56. Meta-Analysis 100%
57. Metastatic Carcinoma 10%
58. Nanoparticle 14%
59. Neoplasm 17%
60. Nephropathy 6%
61. Network Meta-Analysis 10%
62. Nuclear Magnetic Resonance 7%
63. Obstructive Sleep Apnea 6%
64. Odds Ratio 12%
65. Oral Implants 7%
66. Orthopedics 7%
67. Osseointegration 8%
68. Ossification 8%
69. Osteoarthritis 14%
70. Osteolysis 8%
71. Pedicle 6%
72. Photodynamic Therapy 9%
73. Placebo 6%
74. Platelet 29%
75. Platelet Lysate 24%
76. Platelet-Rich Fibrin 7%
77. Postoperative Pain 7%
78. Programmed Cell Death 10%
79. Quality of Life 10%
80. Radiation Therapy 9%
81. Random Effects Model 7%
82. Randomized Controlled Trial 67%
83. Recurrent Disease 6%
84. Rehabilitation Engineering 10%
85. Restylane 25%
86. Signal Transduction 9%
87. Spinal Cord Injury 9%
88. Stem Cell 9%
89. Surgeon 6%
90. Surgery 10%
91. Suture Material 6%
92. Symptom 14%
93. Systematic Review 71%
94. Tendon Graft 6%
95. Thrombocyte Concentrate 10%
96. Thrombocyte Rich Plasma 10%
97. Traumatic Brain Injury 12%
98. Urination 6%
99. Visual Analog Scale 6%
100. Wound Healing 8%

Pharmacology, Toxicology and Pharmaceutical Science

1. Adverse Event 15%
2. Alginic Acid 10%
3. Alkaline Phosphatase 6%
4. All Cause Mortality 6%
5. Aminolevulinic Acid 8%
6. Anti-Inflammatory Drug 8%
7. Anticarcinogen 12%
8. Antiinfective Agent 15%
9. Antioxidant 12%
10. Biocompatibility 9%
11. Biological Marker 5%
12. Breast Cancer 20%
13. Calcium Phosphate 7%
14. Cancer Growth 8%
15. Cardiovascular Disease 6%
16. Cell Viability 12%
17. Chemotherapy 10%
18. Chitosan 38%
19. Chronic Kidney Failure 28%
20. Clinical Trial 8%
21. Cohort Study 10%
22. Collagen Type 1 6%
23. Colorectal Cancer 7%
24. Combination Therapy 16%
25. Cyclooxygenase 2 6%
26. Cytokine 9%
27. Cytotoxicity 15%
28. Diabetes Mellitus 11%
29. Disease 36%
30. Doxorubicin 11%
31. Drug Delivery System 9%
32. Drug Release 6%
33. Dry Eye 8%
34. Epidermal Growth Factor Receptor 12%
35. Epigallocatechin Gallate 9%
36. Fibrinogen 6%
37. Fibrosis 5%
38. Fucoidan 17%
39. Gelatin 20%
40. Glioblastoma 8%
41. Growth Factor 9%
42. Hemodialysis 24%
43. Hyaluronic Acid 22%
44. Hydroxyapatite 5%
45. IC50 8%
46. Implant 5%
47. Infection 12%
48. Inflammation 24%
49. Injury 11%
50. Integrin 6%
51. Kidney Disease 5%
52. Leporidae 5%
53. Lipopolysaccharide 8%
54. Liposome 17%
55. Liver Cell Carcinoma 7%
56. Lung Cancer 10%
57. Malignant Neoplasm 69%
58. Mesoporous Silica Nanoparticle 10%
59. Micelle 6%
60. Mitogen Activated Protein Kinase 3 5%
61. Mouse 25%
62. Mouse Model 8%
63. Mouth Cancer 7%
64. Nanocarrier 10%
65. Nanomaterial 8%
66. Nanomedicine 6%
67. Nanoparticle 52%
68. Neoplasm 42%
69. Neuroprotective Agent 5%
70. Non Small Cell Lung Cancer 7%
71. Osteoarthritis 11%
72. Osteoclast Differentiation Factor 5%
73. Overall Survival 5%
74. Pharmacokinetics 7%
75. Phosphotransferase 5%
76. Photodynamic Therapy 14%
77. Placebo 11%
78. Polyglutamic Acid 6%
79. Polypyrrole 7%
80. Polysaccharide 7%
81. Prevalence 7%
82. Random Effects Model 6%
83. Randomized Controlled Trial 52%
84. Rat Model 10%
85. Reactive Oxygen Metabolite 10%
86. Resveratrol 6%
87. SARS Coronavirus 5%
88. Side Effect 7%
89. Sleep Disordered Breathing 9%
90. Survival Rate 8%
91. Symptom 11%
92. Therapeutic Effect 10%
93. Thrombocyte Concentrate 6%
94. Thrombosis 5%
95. Traumatic Brain Injury 9%
96. Tumor Growth 8%
97. Tumor Necrosis Factor 6%
98. Western Blot 6%
99. Wound 7%
100. Wound Healing 13%